Outlook: An Intervention to Improve Quality of Life in Serious Illness
Completed · Not applicable
Conditions studied: Neoplasms, Pulmonary Disease, Chronic Obstructive, Heart Failure, Renal Disease
In brief
This study will demonstrate whether an end-of-life preparation and completion intervention reduces anxiety, depression, pain and other symptoms and improves functional status, spiritual well-being, and quality of life. If effective, the intervention offers a brief, inexpensive, and transportable non-physician treatment method for improving the experience of individuals in the latter stages of life-limiting illness.
Key facts
- Study ID
- NCT00939146
- Run by
- Duke University
- People needed
- 154
- Starts
- 2010-02-01
- Expected to finish
- 2013-09-01
- Last updated by the study team
- 2014-02-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Eligible patients must have advanced life-limiting illness as determined by clinical criteria indicative of advance disease. Must be diagnosed with one of the following:
- Cancer: Stage IV metastatic cancer, pancreatic and lung cancers may include Stages III and IV, recurrent/refractory disease (multiple myeloma and related cancers);
- Congestive Heart Failure: NYHA Class III or IV;
- End-Stage Renal Disease: Dialysis dependent;
- Chronic Obstructive Pulmonary Disease: Oxygen dependent.
- Also, eligible patients must receive care for one of the diseases above at Duke University Medical Center, have access to a telephone, live within a 35-mile radius of Durham, be at least 18 years of age, English speaking, and cognitively capable to give informed consent.
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.